SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Alan DeVaney who wrote (1732)7/12/1997 1:54:00 PM
From: Jenna2   of 120523
 
QGLY very attractively positioned for move to 15+ in next few sessions:

Equity per share: $ 0.71
ROE for last quarter: 56%
Current ratio: 1.90

% net profit margin last Q: 29%
Debt to equity ratio: .08

I've had this stock last summer, when it was first highly praised and then dismissed after a really bad expose from Barron's. It's cold-eeze is supposed to relieve cold suffering about 30% or so... During winter of 1996 it was impossible to find them on the shelves... I don't know what happened this winter, but when I looked at the stock I noted it was now followed by Zacks, Hoover's, Macro*World and given a respect that was denied to it last year. It is perhaps similar to ENML which has gone from 7 to 16 in a span of 3 months... These stocks tend to base for months then have a wild breakout before settling down to base for another 3-4 months... Looks likes this 'hybernating' biotechnology company is good for another 10% or so short term at least...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext